https://www.selleckchem.com/products/etc-159.html
Alpelisib, a molecular targeted drug against PIK3CA activating mutations, exerted a significant antitumor effect in canine PIK3CA‑mutated HSA cell lines. By contrast, it had no significant effect on canine mammary gland tumor cell lines harboring PIK3CA mutations. On the whole, the findings of the present study suggest that alpelisib may be highly effective against PIK3CA mutations that occur frequently in canine HSA.Mitochondria are key organelles of cellular energy metabolism; both mitochondrial function and metabolism determine the p
Like
Comment
Share
